Autoantibody Discovery, Assay Development and Adoption: Death Valley, the Sea of Survival and Beyond.

Despite an initial phase of triumph of having successfully traversed ‘death valley’, some innovations simply do not survive in the ‘sea of survival’ because of technological advances, economic considerations (investors, managers, client’s shifting priorities) and an increasing trend to central procurement where other factors that do not include true performance of a biomarker may not be the primary factor of interest.

also in 63,971 other papers